On March 5, 2024, Orgenesis Inc. closed the transaction. The company received $2,340,903 in funding pursuant to exemption provided under Regulation D. The transaction included participation from 46 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5071 USD | +0.62% | +1.24% | +1.28% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+1.28% | 17.27M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it has received $2.340901 million in funding